Validation of hemoglobin measurement in venous blood using HemoCue for the Ensanut 2022.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS

ACS Applied Bio Materials Pub Date : 2023-11-13 DOI:10.21149/15063

Vanessa De la Cruz-Góngora, Ignacio Méndez-Gómez Humarán, Socorro Jaimes-Terán, Miguel Gaytán, Luz María Gómez-Acosta, Norma Isela Vizuet-Vega, Elsa Berenice Gaona-Pineda, Lucia Cuevas-Nasu, Martín Romero, Omar Dary, Teresa Shamah-Levy

{"title":"Validation of hemoglobin measurement in venous blood using HemoCue for the Ensanut 2022.","authors":"Vanessa De la Cruz-Góngora, Ignacio Méndez-Gómez Humarán, Socorro Jaimes-Terán, Miguel Gaytán, Luz María Gómez-Acosta, Norma Isela Vizuet-Vega, Elsa Berenice Gaona-Pineda, Lucia Cuevas-Nasu, Martín Romero, Omar Dary, Teresa Shamah-Levy","doi":"10.21149/15063","DOIUrl":null,"url":null,"abstract":"Objective: To validate hemoglobin (Hb) concentration in venous blood (VB) using the HemoCue 201+ in a subsample of children and women from the Mexican National Health and Nutrition Survey 2022.Materials and methods: Prior to field work 50 HemoCue 201+ devices were verified using venous blood. During the field work 57 children (aged 1-11) and 62 women (aged 12-49) donated 3 mL of VB each. Hb was measured in each device of HemoCue 201+ and in a hematologic autoanalyzer for the validation.Results: No significant bias was found in most of the devices. An adjustment criterion was used for 22 devices. Hb mean difference results were -0.049±0.578 g/dL in children and -0.098±0.628 g/dL in women.Conclusions: The HemoCue 201+ is a valid tool for estimating Hb concentration to produce reliable estimates of anemia prevalence when using venous blood.","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2023-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21149/15063","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: To validate hemoglobin (Hb) concentration in venous blood (VB) using the HemoCue 201+ in a subsample of children and women from the Mexican National Health and Nutrition Survey 2022.

Materials and methods: Prior to field work 50 HemoCue 201+ devices were verified using venous blood. During the field work 57 children (aged 1-11) and 62 women (aged 12-49) donated 3 mL of VB each. Hb was measured in each device of HemoCue 201+ and in a hematologic autoanalyzer for the validation.

Results: No significant bias was found in most of the devices. An adjustment criterion was used for 22 devices. Hb mean difference results were -0.049±0.578 g/dL in children and -0.098±0.628 g/dL in women.

Conclusions: The HemoCue 201+ is a valid tool for estimating Hb concentration to produce reliable estimates of anemia prevalence when using venous blood.

查看原文本刊更多论文

使用 Ensanut 2022 HemoCue 验证静脉血中的血红蛋白测量。

目的在 2022 年墨西哥全国健康与营养调查的儿童和妇女子样本中使用 HemoCue 201+ 验证静脉血（VB）中的血红蛋白（Hb）浓度：在实地考察之前，使用静脉血对 50 台 HemoCue 201+ 设备进行了验证。在实地工作期间，57 名儿童（1-11 岁）和 62 名妇女（12-49 岁）分别捐献了 3 毫升静脉血。每个 HemoCue 201+ 设备和一台血液自动分析仪都测量了血红蛋白，以进行验证：结果：大多数设备未发现明显偏差。对 22 台设备采用了调整标准。儿童和妇女的血红蛋白平均差分别为-0.049±0.578 g/dL和-0.098±0.628 g/dL：结论：HemoCue 201+ 是估算 Hb 浓度的有效工具，可在使用静脉血时可靠地估算贫血患病率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

ACS Applied Bio Materials Chemistry-Chemistry (all)

CiteScore

9.40

自引率

2.10%

发文量

464